News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Post Navigation Previous Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 EHR Healthcare News Patient Care Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships Staff December 23, 2024 Financial Healthcare Hospitals News Veterans CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS Staff December 23, 2024
